FUJIFILM Diosynth Biotechnologies is a world-leading contract development and manufacturing organization. It operates a highly automated multipurpose manufacturing facility in College Station, Texas, and has signed a 10-year agreement with Regeneron.
Subscribe to see Fujifilm Diosynth Biotechnologies’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Fujifilm Diosynth Biotechnologies is a biotech company headquartered in Ireland. Xcout tracks 11 named people at Fujifilm Diosynth Biotechnologies, including Maja Pedersen (Chief Operating Officer). Xcout recorded 65 job postings from Fujifilm Diosynth Biotechnologies in the last 90 days, naming tools such as Alteryx, SAP, Tableau.
5 more named people on record for Fujifilm Diosynth Biotechnologies, with roles, board committees and tenure — see the full roster →
Xcout recorded 65 job postings from Fujifilm Diosynth Biotechnologies in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Fujifilm Diosynth Biotechnologies's hiring signals →
Based on 65 job postings in the last 8 weeks (24 Aug – 18 Oct 2026), compared with 221 enterprise healthcare companies.
This describes a hiring pattern — how often Fujifilm Diosynth Biotechnologies’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
A few of Fujifilm Diosynth Biotechnologies's closest competitors — see the full list of competitors and alternatives →
Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Mytos is a biotechnology research and automation company headquartered in London, United Kingdom. Its automation technology enables faster cell culture scaling and cleanroom batch production at a lower cost.
Selexis SA is a Swiss biotechnology company that develops mammalian cell-line development technologies and provides cell-line engineering and development services for biopharmaceutical companies. Its platforms support the production of therapeutic proteins and biologics, serving drug developers and manufacturers.
iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioprocessing. The company's leading therapeutic candidate, IBIO-100, is currently progressing through investigational new drug (IND) development, aimed at addressing systemic scleroderma and idiopathic pulmonary fibrosis. Additionally, iBio is engaged in the preclinical development of vaccine candidates, including IBIO-200 and IBIO-201, designed to prevent severe acute respiratory syndrome coronavirus 2. Another candidate, IBIO-400, is in development for the treatment of classical swine fever. Beyond its proprietary pipeline, iBio provides recombinant proteins to third parties, available both as catalog items and custom-synthesized products. It also offers comprehensive services spanning process development, advanced manufacturing, filling and finishing, and bioanalytical support. iBio maintains several strategic partnerships: a licensing agreement with Planet Biotechnology, Inc. for infectious disease therapeutics; a collaborative effort with The Texas A&M University System focused on COVID-19 vaccine candidates; a licensing pact with the University of Natural Resources and Life Sciences, Vienna; and a collaboration with CC-Pharming Ltd. Its corporate headquarters are situated in Bryan, Texas.
KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO) headquartered in Durham, North Carolina. The company specializes in cell line development, analytical testing, and process manufacturing services for biopharmaceutical clients worldwide.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Fujifilm Diosynth Biotechnologies? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.